首页> 外文期刊>Diabetes, obesity & metabolism >Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK - a nested case-control analysis
【24h】

Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK - a nested case-control analysis

机译:英国经治疗的2型糖尿病患者严重低血糖的发生率和危险因素-嵌套病例对照分析

获取原文
获取原文并翻译 | 示例
           

摘要

To assess incidence rates (IRs) of and identify risk factors for incident severe hypoglycaemia in patients with type 2 diabetes newly treated with antidiabetic drugs. Methods: Using the UK-based General Practice Research Database, we performed a retrospective cohort study between 1994 and 2011 and a nested case-control analysis. Ten controls from the population at risk were matched to each case with a recorded severe hypoglycaemia during follow-up on general practice, years of history in the database and calendar time. Using multivariate conditional logistic regression analyses, we adjusted for potential confounders. Results: Of 130761 patients with newly treated type 2 diabetes (mean age 61.7±13.0years), 690 (0.5%) had an incident episode of severe hypoglycaemia recorded [estimated IR 11.97 (95% confidence interval, CI, 11.11-12.90) per 10000 person-years (PYs)]. The IR was markedly higher in insulin users [49.64 (95% CI, 44.08-55.89) per 10000 PYs] than in patients not using insulin [8.03 (95% CI, 7.30-8.84) per 10000 PYs]. Based on results of the nested case-control analysis increasing age [≥75 vs. 20-59years; adjusted odds ratio (OR), 2.27; 95% CI, 1.65-3.12], cognitive impairment/dementia (adjusted OR, 2.00; 95% CI, 1.37-2.91), renal failure (adjusted OR, 1.34; 95% CI, 1.04-1.71), current use of sulphonylureas (adjusted OR, 4.45; 95% CI, 3.53-5.60) and current insulin use (adjusted OR, 11.83; 95% CI, 9.00-15.54) were all associated with an increased risk of severe hypoglycaemia. Conclusions: Severe hypoglycaemia was recorded in 12 cases per 10000 PYs. Risk factors for severe hypoglycaemia included increasing age, renal failure, cognitive impairment/dementia, and current use of insulin or sulphonylureas.
机译:评估使用抗糖尿病药物新治疗的2型糖尿病患者严重低血糖的发生率(IR)并确定危险因素。方法:我们使用位于英国的全科医学研究数据库,进行了1994年至2011年的回顾性队列研究和嵌套病例对照分析。在常规实践,数据库中的病史和日历时间的随访中,将十名有风险人群的对照组与每例病例相匹配,并记录下严重的低血糖。使用多元条件逻辑回归分析,我们对潜在的混杂因素进行了调整。结果:在130761名新治疗的2型糖尿病患者(平均年龄61.7±13.0岁)中,有690名(0.5%)发生了严重的低血糖事件[记录的IR 11.97(95%置信区间,CI,11.11-12.90)]。 10000人年(PYs)]。与未使用胰岛素的患者相比,胰岛素使用者的IR显着更高[49.64(95%CI,44.08-55.89)/每10000 PYs] [8.03(95%CI,7.30-8.84)/每10000 PYs]。根据巢式病例对照分析的结果,年龄增加了[≥75岁vs. 20-59岁;调整后的优势比(OR)为2.27; 95%CI,1.65-3.12],认知障碍/痴呆(OR调整后,2.00; 95%CI,1.37-2.91),肾衰竭(OR,调整后1.34; 95%CI,1.04-1.71),磺脲类药物的当前使用(调整后的OR,4.45; 95%CI,3.53-5.60)和当前的胰岛素使用(调整后的OR,11.83; 95%CI,9.00-15.54)均与严重低血糖的风险增加相关。结论:每10000 PYs中有12例发生严重低血糖。严重低血糖的危险因素包括年龄增长,肾衰竭,认知障碍/痴呆以及当前使用胰岛素或磺脲类药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号